| P2093 | author name string | K W Gross | |
| | C A Jones | |
| | C M LeVea | |
| | G Hajduczok | |
| | S M Caraker | |
| | S Sexton | |
| | S T Glenn | |
| P2860 | cites work | Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia | Q28143642 |
| | Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice | Q28507607 |
| | Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1 | Q28588869 |
| | A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors | Q28592210 |
| | Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 |
| | Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells | Q29619410 |
| | Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened | Q30433495 |
| | Cooperative tumorigenic effects of germline mutations in Rb and p53 | Q72781894 |
| | Expression of a renin/GFP transgene in mouse embryonic, extra-embryonic, and adult tissues | Q73178667 |
| | Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1 | Q73557853 |
| | The tissue renin-angiotensin system in human pancreas | Q77731503 |
| | Neuroendocrine tumors of the pancreas | Q83762285 |
| | Role of angiotensin in renal vascular development. | Q30472568 |
| | General method for the modification of different BAC types and the rapid generation of BAC transgenic mice | Q33197306 |
| | Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations | Q33425920 |
| | What have we learned from gene targeting studies for the renin angiotensin system of the kidney? | Q33653909 |
| | Expression of murine renin genes in subcutaneous connective tissue | Q33844159 |
| | Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity | Q33965112 |
| | Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. | Q34078091 |
| | Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice | Q34132545 |
| | Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway. | Q34146539 |
| | Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas | Q34296586 |
| | The renin-angiotensin system in the endocrine pancreas | Q34542474 |
| | The pancreatic renin-angiotensin system: does it play a role in endocrine oncology? | Q34542487 |
| | Role of endothelial cells in early pancreas and liver development | Q35029661 |
| | A local pancreatic renin-angiotensin system: endocrine and exocrine roles | Q35099138 |
| | Of mice and MEN1: Insulinomas in a conditional mouse knockout | Q35660901 |
| | Clinical anticancer drug development: targeting the cyclin-dependent kinases | Q35959477 |
| | Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus | Q36102603 |
| | Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes. | Q36273818 |
| | The physiology of a local renin-angiotensin system in the pancreas | Q36705812 |
| | Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains | Q36721554 |
| | Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors | Q36959997 |
| | In vivo analysis of key elements within the renin regulatory region | Q36977789 |
| | Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. | Q37429020 |
| | Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6. | Q39320072 |
| | Pancreatic glucagonoma with and without syndrome. Immunocytochemical study of 5 tumour cases and review of the literature | Q40123472 |
| | Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum | Q40442891 |
| | Expression of neurogenin3 reveals an islet cell precursor population in the pancreas | Q40867538 |
| | Pancreatic neurogenin 3-expressing cells are unipotent islet precursors | Q42102476 |
| | Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. | Q42648216 |
| | Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. | Q42810962 |
| | Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin | Q43467108 |
| | Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes | Q43470250 |
| | Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets | Q44727498 |
| | Angiotensin II type 2 receptor is critical for the development of human fetal pancreatic progenitor cells into islet-like cell clusters and their potential for transplantation | Q46300746 |
| | Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis | Q46782176 |
| | Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. | Q52544495 |
| | Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. | Q53378102 |
| | Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. | Q55043460 |
| | Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours | Q60585297 |
| | Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides | Q61852966 |
| P433 | issue | 50 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| P304 | page(s) | 5706-5715 | |
| P577 | publication date | 2013-12-02 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma | |
| P478 | volume | 33 | |